Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 20, 2005
J Am Soc Nephrol 16: 2714-2723, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005010045

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005010045v1
16/9/2714    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laxmanan, S.
Right arrow Articles by Pal, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laxmanan, S.
Right arrow Articles by Pal, S.

Pathophysiology of Renal Disease and Progression

CD40: A Mediator of Pro- and Anti-Inflammatory Signals in Renal Tubular Epithelial Cells

Sreenivas Laxmanan*,{dagger},{ddagger}, Dipak Datta*,{dagger},{ddagger}, Christopher Geehan*,{dagger},{ddagger}, David M. Briscoe*,{dagger},{ddagger} and Soumitro Pal*,{dagger},{ddagger}

* Division of Nephrology; {dagger} Transplantation Research Center, Children’s Hospital Boston and Brigham and Women’s Hospital; and {ddagger} Department of Pediatrics, Harvard Medical School, Boston, Massachusetts

Address correspondence to: Dr. Soumitro Pal, Division of Nephrology, Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115. Phone: 617-919-2989; Fax: 617-730-0130; soumitro.pal{at}childrens.harvard.edu

Received for publication January 11, 2005. Accepted for publication June 14, 2005.

Infiltration of immune cells into the renal interstitium is characteristic of chronic inflammatory kidney diseases. CD4+ T cells and platelets express CD40 ligand (CD40L) and are reported to mediate proinflammatory events in renal proximal tubular epithelial cells (RPTEC) via interaction with CD40. In other cell types, CD40 signals can also induce protective genes. Here, human RPTEC were treated with sCD40L to ligate CD40, and a significant increase in the generation of proinflammatory reactive oxygen species was found; however, CD40-activated cells did not undergo apoptosis. This suggests that CD40 signals may simultaneously induce antiapoptotic genes for cytoprotection of RPTEC. Heme oxygenase-1 (HO-1) expressed in RPTEC serves as a protective gene, but it is not known whether it is regulated by CD40. Next, RPTEC were transiently transfected with a full-length HO-1 promoter-luciferase construct and were treated with sCD40L. CD40 ligation was found to significantly increase HO-1 promoter activity. By electrophoretic mobility shift assay, it was confirmed that CD40 signaling induced the transcriptional activation of HO-1 through the binding of NF-{kappa}B to its promoter. By Western blot analysis, a marked increase in HO-1 protein expression following CD40 ligation was also found. These observations are of clinical significance because it was found that CD40 and HO-1 are induced in expression in vivo in inflamed rejecting kidney biopsies and co-expressed in renal tubules. Therefore, ligation of CD40 in RPTEC promotes both inflammatory and anti-inflammatory processes. Regulating the balance between these two events may be of importance in the prevention of tubular injury associated with renal disease.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Datta, O. Dormond, A. Basu, D. M. Briscoe, and S. Pal
Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1222 - F1230.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP